Top

Published in:

01-12-2011 | Original Paper

Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis

Authors: Hasan Aydin, Faruk Yencilek, Ismet Bilger Erihan, Binnur Okan, Kemal Sarica

Published in: Urolithiasis | Issue 6/2011

Abstract

Both the prevalence of cardiovascular risk factors and event rate are increased in patients with urolithiasis. Screening is recommended to all patients who have high cardiovascular risk. The aim of this study was to document 10-year risk of cardiovascular disease and mortality in asymptomatic patients with urolithiasis. Consecutive 200 patients with calcium oxalate urolithiasis were compared with 200 age- and sex-matched healthy controls. Ten-year cardiovascular disease risk was calculated with the Framingham Risk Score and mortality risk with SCORE risk score. Calcium, oxalate, and citrate excretion were studied as urinary stone risk factors. The results indicate that patients with urolithiasis had higher total cholesterol (p < 0.0001), lower HDL-cholesterol (p < 0.0001), and higher systolic blood pressure (p < 0.0001) and hsCRP (p < 0.0001) compared with controls. Patients with urolithiasis had a higher Framingham Risk Scores [OR 8.36 (95% CI 3.81–18.65), p = 0.0001] and SCORE risk score [OR 3.02 (95% CI 1.30–7.02), p = 0.0006] compared with controls. The Framingham and SCORE risk score were significantly correlated with urinary calcium (p = 0.0001, r = 0.460, and p = 0.005, r = 0.223, respectively) and oxalate excretion (p = 0.0001, r = 0.516, p = 0.001, r = 0.290, respectively). In multiple linear regression analysis, urinary calcium and oxalate excretion, age, sex, total cholesterol, HDL-cholesterol, hsCRP and smoking were the independent predictors of 10-year cardiovascular disease risk and urinary calcium and oxalate excretion, age, sex, total cholesterol, fasting blood glucose for 10-year cardiovascular mortality. In conclusion, patients with calcium oxalate urolithiasis carry high risk of cardiovascular disease and mortality. All patients should be screened at the initial diagnosis of urolithiasis for the risk factors.

Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823PubMedCrossRef

Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O’Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2009) Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119(3):e21–e181PubMedCrossRef

Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462PubMedCrossRef

Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230–1235PubMedCrossRef

Cirillo M, Laurenzi M (1988) Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens Suppl 6(4):S485–S486PubMed

Traxer O, Safar H, Daudon M, Haymann JP (2006) Metabolic syndrome, obesity and urolithiasis. Prog Urol 16(4):418–420PubMed

Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21(10):1641–1644PubMedCrossRef

WritingCommittee Members, Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122(25):e584–e636PubMedCrossRef

Kappagoda CT, Amsterdam EA (2009) Assessment of risk for developing coronary heart disease in asymptomatic individuals. J Cardiopulm Rehabil Prev 29(4):207–219PubMed

10.

Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24(11):987–1003PubMedCrossRef

11.

Raynal G, Achkar K, El Samad R, Kikassa JC, Jorest R (2008) Cardiovascular risk associated with urolithiasis. Prog Urol 18(5):288–291PubMedCrossRef

12.

Domingos F, Serra A (2011) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 26(3):864–868

13.

Zimmerer T, Weiss C, Hammes HP, Braun C, Hesse A, Alken P, Knoll T (2009) Evaluation of urolithiasis: a link between stone formation and diabetes mellitus? Urol Int 82(3):350–355PubMedCrossRef

14.

Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21(3):257–264PubMedCrossRef

15.

West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51(5):741–747PubMedCrossRef

16.

Mossetti G, Rendina D, De Filippo G, Benvenuto D, Vivona CL, Zampa G, Ferraro P, Strazzullo P (2008) Metabolic syndrome and nephrolithiasis: can we hypotize a common background? Clin Cases Mineral Bone Metab 5(2):114–117

17.

Daudon M, Doré JC, Jungers P, Lacour B (2004) Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 32(3):241–247PubMedCrossRef

18.

Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359PubMedCrossRef

19.

Ford ES (2004) Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 33(2):333–350PubMedCrossRef

20.

Costa EC, de Sá JC, Soares EM, Lemos TM, Maranhão TM, Azevedo GD (2010) Evaluation of cardiovascular risk by the LAP index in non-obese patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol 54(7):630–635PubMedCrossRef

21.

Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363(14):1341–1350PubMedCrossRef

22.

Ljunghall S, Hedstrand H (1976) Renal stones and coronary heart disease. Acta Med Scand 199(6):481–485PubMedCrossRef

23.

Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874PubMedCrossRef

24.

Tsao KC, Wu TL, Chang PY, Sun CF, Wu LL, Wu JT (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21(6):426–431PubMedCrossRef

25.

Cupisti A, Meola M, D’Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G (2007) Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother 61(1):86–90PubMedCrossRef

26.

Eisner BH, Eisenberg ML, Stoller ML (2010) Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Urology 75(6):1289–1293PubMedCrossRef

27.

Chou YH, Su CM, Li CC, Liu CC, Liu ME, Wu WJ, Juan YS (2010) Difference in urinary stone components between obese and non-obese patients. Urol Res (Epub ahead of print)

28.

Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun M (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363(23):2211–2219PubMedCrossRef

Title: Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis
Authors: Hasan Aydin
Faruk Yencilek
Ismet Bilger Erihan
Binnur Okan
Kemal Sarica
Publication date: 01-12-2011
Publisher: Springer-Verlag
Published in: Urolithiasis / Issue 6/2011
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-011-0383-9

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2011

Flow matters: irrigation flow differs in flexible ureteroscopes of the newest generation

Percutaneous nephrolithotomy in semisupine position: a modified approach for renal calculus

The efficacy of a novel antibacterial hydroxyapatite nanoparticle-coated indwelling urinary catheter in preventing biofilm formation and catheter-associated urinary tract infection in rabbits

Giant renal calculus in a horseshoe kidney presenting as an abdominal lump

Tamsulosin does not have greater efficacy than conventional treatment for distal ureteral stone expulsion in Mexican patients

Aggregation of freshly precipitated calcium oxalate crystals in urine of calcium stone patients and controls